Stem cell scientist Hwang's 2004 Science paper faked, panel says

SEOUL, South Korea - Surrounded by a bid assembly of media members, Chung Myung Hee, chief of the Seoul National University's investigation committee, speaks at a press conference in Seoul on Jan. 10. Chung said that the university's disgraced stem cell scientist Hwang Woo Suk had faked research results on his production of the embryonic stem cells, published in the U.S. journal Science in 2004. (Kyodo)

Sample
PDF Preview

Product Code
ILEA000031243

Registered date
2006/1/10 00:00:00

Credit
Kyodo / Kyodo News Images

Media source

Media size
1664 × 1228 pixel

Resolution
72 dpi

Deployment size
616.59(KB)*

Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa (L) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa (R) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo

World's 1st transplant of iPS heart muscle tissue

Osaka University professor Yoshiki Sawa (C) attends a press conference in Suita, Osaka Prefecture, on Jan. 27, 2020, to announce the world's first transplant of heart muscle tissue using artificially derived stem cells known as iPS. (Kyodo) ==Kyodo

World's 1st transplant of iPS heart muscle tissue

World's 1st test using iPS cells to treat corneal disease

Osaka University professor Koji Nishida speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo

World's 1st test using iPS cells to treat corneal disease

Osaka University professor Koji Nishida (2nd from R) speaks at a press conference in Tokyo on March 5, 2019, about the world's first clinical test to treat patients with a corneal disease by using artificially derived stem cells. (Kyodo) ==Kyodo

Nobel laureate researcher Shinya Yamanaka

Nobel laureate researcher Shinya Yamanaka, who heads Kyoto University's Center for iPS Cell Research and Application, speaks at a press conference in Kyoto on Dec. 18, 2018. (Kyodo) ==Kyodo

Nobel laureate researcher Shinya Yamanaka

KYOTO, Japan, Dec. 19 Kyodo - Nobel laureate researcher Shinya Yamanaka, who heads Kyoto University's Center for iPS Cell Research and Application, speaks at a press conference in Kyoto on Dec. 18, 2018.